According to a new report published by K D Market Insights, titled, “3D Cell Culture Market Insights, Trends, Opportunity & Forecast, 2023–2032,” the global 3D cell culture market size is anticipated to witness moderate growth during the forecast period i.e., 2023-2032. The reason behind the growth can be attributed to the increasing call for customized medicine and regenerative medicinal drug, growing occurrence of persistent illnesses, the growth of pharmaceutical and biotechnology industries and the appearance of automation and robotics in 3-D cellular institution which are the major factors augmenting the growth of the global 3D cell culture market. The global 3D cell culture market is anticipated to grow at a high CAGR of 14.6% from 2023 to 2032. The market’s revenue surged to $1.1 billion in 2022, and it is expected to further accelerate, reaching a notable $4.4 billion by 2032.
The increasing demand for personalized medication and regenerative medication, is further expected to create ample growth opportunities for the global 3D cell culture market during the forecast period i.e., 2023-2032. Moreover, growing occurrence of continual diseases, including cancer and cardiovascular illnesses, has led to an expanded attention on drug discovery and development, has propelled market expansion. The increasing pharmaceutical and biotechnology industries, especially in growing regions, is expected to contribute towards the market growth during the period.
The North America region accounted for the largest share in the global 3D cell culture market in 2022. The region is further projected to continue dominating in the market during the forecast period. This can be attributed to the emphasis on drug discovery, rise of personalized medicine in pharmaceutical and biotechnology companies
According to product, the scaffold-based 3D cell cultures segment accounted for the largest market share in the 3D cell culture market in 2022 and is further expected to continue with the trend during the forecast period i.e., 2023 – 2032.
The global 3D cell culture market is segmented into product, application, end-users and region. Based on product, the market is bifurcated into (scaffold-based 3D cell cultures, scaffold-free 3d cell cultures, microfluidics-based 3d cell cultures, magnetic & bioprinted 3D cell cultures. Based on application, it is classified into cancer & stem cell research, drug discovery & toxicology testing, tissue engineering & regenerative medicine. Based on end-users, it is classified into pharmaceutical & biotechnology companies, research institutes, cosmetics industry, other end users.
Related Reports :-
https://www.kdmarketinsights.com/reports/health-telementry-system-market-2017/301
https://www.kdmarketinsights.com/reports/ph-strips-market/236
https://www.kdmarketinsights.com/reports/stairlifts-market/234
https://www.kdmarketinsights.com/reports/pet-nutrition-and-dietary-supplements-market/232
The global 3D cell culture market is analyzed across North America (U.S. & Canada), Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Indonesia, Thailand, Australia, New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America) and Middle East & Africa (GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, and Rest of Middle East & Africa).
Key Insights of 3D Cell Culture Market
- On the basis of product, the scaffold-based 3D cell cultures segment accounted for the largest market share in the 3D cell culture market in 2022 and is further expected to continue with the trend during the forecast period i.e., 2023 – 2032.
- On the basis of region, North America accounted for the largest share in the global 3D cell culture market in 2022. The region is further projected to continue dominating in the market during the forecast period.
- On the basis of region, Asia-Pacific is estimated to account for the second largest share in the market during the forecast period.
Some of the major 3D cell culture companies profiled in the report include Thermo Fisher Scientific, Merck KGaA, Lonza, Corning Incorporated, Avantor Inc., Tecan Trading AG, REPROCELL Inc., Advanced Biomatrix, Inc., CN Bio Innovations Ltd., Lena Biosciences.